A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

• Published in: Journal of pharmacopuncture Vol. 22; no. 4; pp. 225 - 230
• Main Authors: Kim, Seok Hee, Yang, Jin Won, Kim, Kyung Han, Kim, Jong Uk, Yook, Tae Han
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Pharmacopuncture Institute (KPI) 01-12-2019; Korean Pharmacopuncture Institute; 대한약침학회
• Subjects: ad(alzheimer’s diseas); cbd(cannabidiol); marijuana; Review; thc(δ-tetrahydrocannabidiol); 한의학; CBD(Cannabidiol); Marijuana; AD(Alzheimer’s diseas); THC(Δ-tetrahydrocannabidiol)
• ISSN: 2093-6966; 2234-6856
• DOI: 10.3831/kpi.2019.22.030

This study was to discuss the research trend of dementia treatment using cannabis for the purpose of providing the basis of cannabis use for medical purposes in the future.
This study searched publications, which were registered to databases or published by Aug 22, 2019, and targeted the full-text or abstracts of these publications. We selected the final nine studies met all selection criteria.
These results implied that the CBD components of cannabis might be useful to treat and prevent AD because CBD components could suppress the main causal factors of AD. Moreover, it was suggested that using CBD and THC together could be more useful than using CBD or THC alone.
We hope that there will be a solid foundation to use cannabis for medical use by continuously evaluating the possibility of using cannabis for clinical purposes as a dementia treatment substance and cannabis can be used as a positive tool.